Skip to main content
Download PDF

Andrographolide sodium bisulphite-induced inactivation of urease: inhibitory potency, kinetics and mechanism

BMC Complementary and Alternative Medicine volume 15, Article number: 238 (2015) Cite this article

Abstract

Background

The inhibitory effect of andrographolide sodium bisulphite (ASB) on jack bean urease (JBU) and Helicobacter pylori urease (HPU) was performed to elucidate the inhibitory potency, kinetics and mechanism of inhibition in 20 mM phosphate buffer, pH 7.0, 2 mM EDTA, 25 °C.

Methods

The ammonia formations, indicator of urease activity, were examined using modified spectrophotometric Berthelot (phenol-hypochlorite) method. The inhibitory effect of ASB was characterized with IC50 values. Lineweaver-Burk and Dixon plots for JBU inhibition of ASB was constructed from the kinetic data. SH-blocking reagents and competitive active site Ni2+ binding inhibitors were employed for mechanism study. Molecular docking technique was used to provide some information on binding conformations as well as confirm the inhibition mode.

Results

The IC50 of ASB against JBU and HPU was 3.28 ± 0.13 mM and 3.17 ± 0.34 mM, respectively. The inhibition proved to be competitive and concentration- dependent in a slow-binding progress. The rapid formation of initial ASB-JBU complex with an inhibition constant of K i  = 2.86 × 10−3 mM was followed by a slow isomerization into the final complex with an overall inhibition constant of K i * = 1.33 × 10−4 mM. The protective experiment proved that the urease active site is involved in the binding of ASB. Thiol reagents (L-cysteine and dithiothreithol) strongly protect the enzyme from the loss of enzymatic activity, while boric acid and fluoride show weaker protection, indicating that the active-site sulfhydryl group of JBU was potentially involved in the blocking process. Moreover, inhibition of ASB proved to be reversible since ASB-inactivated JBU could be reactivated by dithiothreitol application. Molecular docking assay suggested that ASB made contacts with the important sulfhydryl group Cys-592 residue and restricted the mobility of the active-site flap.

Conclusions

ASB was a competitive inhibitor targeting thiol groups of urease in a slow-binding manner both reversibly and concentration-dependently, serving as a promising urease inhibitor for the treatment of urease-related diseases.

Peer Review reports

Background

Urease (urea amidohydrolase, EC 3.5.1.5) which catalyzes the hydrolysis of urea to produce ammonia and carbon dioxide has been found in plants, algae, fungi, bacteria and soil [1]. It is a thiol-rich and nickel-dependent metalloenzyme that can catalyze the hydrolysis of urea, thereby producing ammonia and carbamate [2]. In addition to the archetypical nickel-containing urease, Helicobacter mustelae, a gastric pathogen of ferrets, was recently found to synthesize a distinct iron-dependent oxygen-labile urease with dinuclear Fe and less activity [3]. Nevertheless, the nickel ions (Ni2+) and the sulfhydryl group, especially the multiple cysteinyl residues in the active site of the enzyme, are essential for the catalytic activity of all ureases. As the reaction results in the increase of pH values, urease is responsible for negative effects of urease activity in human health and agriculture.

Helicobacter pylori (H. pylori) is a well-established etiologic agent of gastritis, gastric and duodenal ulceration, even gastric carcinoma [4]. H. pylori urease (HPU), a highly active urease produced by H. pylori, is a virulence factor in infections of gastrointestinal tracts. HPU could initiate the hydrolysis of urea generating ammonia, which allows the bacterium to survive and colonize the low pH environment of the gastric mucosa [5]. Therefore, strategies based on urease inhibition are now considered as the first line of treatment for infections caused by urease-producing microorganisms.

In past decades, varieties of urease inhibitors have been investigated including phosphoramidates [2], hydroxamic acids [6], boric and boronic acids [7], heavy metal ions [8], quinones [9] and imidazoles [10]. However, most of these compounds are too toxic or unstable to be therapeutic agents. Thus, current researches are focused on finding novel urease inhibitors with promising levels of activity from natural plant.

Andrographolide (C20H30O5), the major diterpenoid lactone and the primary effective constituent of Andrographis paniculata (a widely used Chinese medicinal herb known as ‘Chuan-Xin-Lian’ in Chinese), has multiple pharmacological properties, including antimicrobial [11], anti-inflammation [12, 13], anti–cancer [14] and immunity enhancement [15–17]. Andrographis paniculata was reported to posses anti-H. pylori activity [18] and effectively relieve H. pylori associated gastritis in clinical practice [19, 20]. In addition, a variety of andrographolide derivatives proved to exert inhibitory effects on enzymes [21–23]. Therefore, andrographolide is expected to exert inhibitory properties against urease, counteracting the undesirable effects brought about by activated urease. Jack bean urease (JBU) is the best-characterized [24–26] and widely-employed instrumental enzyme in urease inhibition research [27, 28]. Additionally, it has been found that the inhibition mechanism of action and kinetics of inhibition for bacteria urease and JBU are similar [29]. In the present investigation, the inhibitory effect against JBU of andrographolide sodium bisulphite (ASB, C20H29O7S · Na, shown in Fig. 1), a water-soluble sulfonate of andrographolide, was performed to elucidate the kinetics and mechanism of inhibition.

Fig. 1
figure 1

Chemical structure of ASB

Full size image

Methods

Materials and reagents

Andrographolide sodium bisulfite (C20H29O7S · Na, CAS number 71202-97-6), urea (molecular biology reagent), D,L-dithiothreitol (DTT) , L-cysteine (L-cys), boric acid and sodium fluoride (NaF) were purchased from Sigma Aldrich. JBU (from jack bean, Canavalia ensiformis, type III, nominal activity 40.3 units/mg, solid) was also from Sigma Aldrich, of which one unit of urease activity is defined as the amount of enzyme needed to liberate 1.0 μmol of NH3 from urea per min at pH 7.0 at 25 °C. Brucella broth was purchased from Becton–Dickinson. (Cockeysville, MD). Other chemicals were obtained from Guangzhou Chemical Reagent Factory (China). All reagents were of analytical grade. Phosphate buffer (PBS, 20 mM, pH 7.0) was prepared by adjusting pH of phosphoric acid with NaOH. 2 mM EDTA was added to all enzyme-containing solutions.

Preparation of H. pylori urease

Helicobacter pylori (ATCC 43504; American Type Culture Collection, Manassas, VA) was grown in brucella broth supplemented with 10 % heat-inactivated horse serum for 24 h at 37 °C under microaerobic conditions (5 % O2, 10 % CO2, and 85 % N2) [30, 31]. For urease inhibition assays, 50 ml broth cultures (2.0 × 108 CFU/mL) were centrifuged (5000 g, 4 °C) to collect the bacteria, and after washing twice with phosphate-buffered saline (pH 7.4), the H. pylori precipitation was stored at -80 °C. H. pylori was returned to room temperature, and after addition of 3 mL of distilled water and protease inhibitors, sonication was performed for 60 s. Following centrifugation (15,000 g, 4 °C), the supernatant was desalted through Sephadex G-25 column (PD-10 columns, Amersham–Pharmacia Biotech, Uppsala, Sweden). The resultant crude urease solution was added to an equal volume of glycerol and stored at 4 °C until use in the experiment.

Standard urease activity assay

The standard urease assay mixture contained 50 mM urea in 20 mM phosphate buffer (pH 7.0) containing 2 mM EDTA. After addition of the enzyme-containing solution of 0.25 mg/mL JBU, the assay ran for 20 min, and the enzyme activity was determined by measuring the concentration of the ammonia released in the reaction mixture. For ammonia measurement, aliquots were withdrawn from the reaction mixtures, and the ammonia was determined at 595 nm spectrophotometrically according to the modified Berthelot (phenol-hypochlorite) method [32] at ambient temperature.

Inactivation of JBU by ASB

Urease solutions mixed with serial concentrations of ASB ( 0–6 mM) were incubated at 37 °C for 20 min, which contained 0.25 mg/mL JBU, 20 mM phosphate buffer (pH 7.0), and 2 mM EDTA. The initial time of incubation was defined as the moment once the enzyme and inhibitor were mixed. After appropriate period of time, aliquots from the incubation mixture were transferred into the standard assay mixtures for urease residual activity determination. The activity of uninhibited urease was defined as the control activity of 100 %.

Determination of K M and v max

The Michaelis constant K M and the maximum velocity v max in the absence of the inhibitor were determined by measuring the initial reaction velocities at different urea concentrations ranging from 0.4 to 10 mM. The values were obtained by applying nonlinear regression to the Michaelis-Menten equation.

Reaction progress curves monitoring

The reaction progress was studied in the absence or presence of ASB using the following two procedures.

  1. (a)

    Unpreincubated System. The progress curves were determined by the reactions directly initiated by the addition of the JBU into the reaction mixtures containing different concentrations of ASB (2, 4 and 6 mM).

  2. (b)

    Preincubated System. The JBU was preincubated with ASB for 20 min first, and the reaction was then initiated by addition of urea solution into the reaction preincubation mixtures containing different concentrations of ASB (2, 4 and 6 m.M).

JBU activities in both procedures were determined as described in standard urease activity assay. A curve-fitting computer program was employed to fit the experimental points to the integrated equation describing slow-binding inhibition progress curves [7]:

$$ p(t)={v}_st+\frac{\left({v}_0-{v}_s\right)\left(1-{e}^{-{k}_{ap{p}^t}}\right)}{k_{app}} $$
(1)

where p is the amount of product accumulated at time t after initiation of the reaction. v 0 and v s are the reaction initial and steady-state velocities, respectively, and k app denotes the apparent first-order velocity constant for interconversion between v 0 and v s .

JBU protection against ASB inactivation

This part of the study was carried out as follows. JBU was first preincubated with different protectors for 20 min. Then, samples of the protected JBU were incubated with 4 mM ASB for additional 20 min. The urease activity was assayed upon incubation of the mixture. For protection by boric acid and NaF, JBU was preincubated with 4 mM boric acid and 4 mM NaF, respectively. For protection by thiols, the applied thiol-containing compounds (L-cys and DTT) were of a series of concentrations.

ASB -thiol-urease interaction test

The incubation mixtures contained JBU solution, ASB, and mono thiols (L-cys) or dithiol (DTT). The components of the incubation mixture were mixed according to the following three procedures:

  1. (a)

    JBU was added to the mixture after a 20 min contact of ASB with the thiol.

  2. (b)

    ASB was added to the mixture after a 20 min contact of JBU with thiol.

  3. (c)

    Thiol was added to the mixture after a 20 min contact of JBU with ASB.

The complete mixture was mixed thoroughly and incubated for additional 5, 10, 20, and 40 min. Then, JBU activity assay was determined as described in the inactivation of JBU by ASB.

Reactivation of ASB -inactivated JBU

The reactivation of inactivated JBU was studied in two ways: by using DTT, L-cys and by multidilution in the reaction mixture containing urea.

  1. (a)

    After a 20 min preincubation of JBU with ASB (4 mM), the mixture was further incubated with DTT or L-cys for 120 min. The activity of JBU was determined before and after the addition of DTT.

  2. (b)

    ASB (4 mM) was preincubated for 10 and 20 min, respectively, with the enzyme to establish the equilibrium: \( E \) + \( I \) ⇔ \( EI \) ⇔ \( EI \) ∗, and then the preincubation mixture was diluted 50 folds into the reaction mixture. After appropriate period of time, aliquots were withdrawn, and the amount of ammonia was determined.

Molecular docking

The automated docking studies were carried out using Auto-Dock version 4.0 as implemented through the graphical user interface AutoDock Tools (ADT 1.5.2). The three-dimensional crystal structure of JBU (PDB code: 3LA4) was obtained from the RCSB Protein Data Bank,whose resolution was 2.05 Å . The required actions were to remove water molecules from the protein, add all hydrogen atoms, calculate Gasteiger charges, and merge nonpolar hydrogen atoms to carbon atoms. The standard 3D structure (PDB format) of ASB was obtained with chem3D Ultra 8.0 software. The PDB files were further transferred to PDBQT files with AutoDock Tools. The three-dimensional results were created by the PyMol molecular graphics system [33]. The cubic grid box of 60 Å size (x, y, z ) with a spacing of 0.5 Å and grid maps were built. The center of the grid was set to the average coordinates of the two Ni2+ ions. The Lamarckian genetic algorithm (LGA) was selected as the search algorithm. The Lamarckian job consisted of 100 runs. Default settings were used with an initial population of 150 randomly placed individuals, a maximum number of 2.5 × 106 energy evaluations, and a maximum number of 2.7 × 104 generations. A mutation rate of 0.02 and a crossover rate of 0.8 were chosen. Van der Waals and hydrogen bonding were included in the calculated non-bonded energy. Results differing by less than 0.5 Å in positional root-mean-square deviation (RMSD) were clustered together, and the results of the most favorable free energy of binding were chosen as the resultant complex structures.

Results and discussion

Urease inhibition assays

The system of jack bean urease-ASB-urea, can be treated as a model system in the studies on the utility of ASB in the therapy of diseases caused by H. pylori and other bacteria producing urease. Data from Fig. 2 depicted urease residual activity as a function of ASB concentration. The IC50 indicated the ASB concentration that could descend the activity of urease to 50 %. The obtained IC50 value of ASB against HPU and JBU was 3.17 ± 0.34 mM (R2 = 0.976) and 3.28 ± 0.13 mM (R2 = 0.997), respectively. The linear function for this relation was a good-enough approximation. Based on the above mentioned, a conclusion could be drawn that ASB performed similar effectiveness on the inhibition of these two ureases.

Fig. 2
figure 2

Dependence of residual activity versus concentration of ASB. a residual activity of JBU inhibited by ASB; b residual activity of HPU inhibited by ASB

Full size image

Kinetics of JBU inactivation by ASB

Enzyme kinetics was determined in the absence and presence of various concentrations of ASB. K M and v max of ureolytic reaction by applying nonlinear regression to the Michaelis-Menten equation were 2.001 ± 0.08 mM and 0.125 ± 0.07 mM/min, respectively. As the Lineweaver-Burk plots for ASB shown in Fig. 3, K M value did not significantly change in the presence of ASB, while the V max value decreased as the ASB concentration increased, indicating that the effect of ASB on JBU might be a noncompetitive mechanism of inhibition. Additionally, our data indicated a slow-binding inhibition relationship of enzyme activity versus preincubation time [9, 34], which indicated the total urease activity in the free form and in the form of being bound in the urease inhibitor complexes EI and EI*. It was clear in Fig. 4 that increasing the preincubation time resulted in a decrease of urease activity. The activity descended rapidly at the beginning until the equilibrium between urease (E), inhibitor (I), and urease-inhibitor complexes (EI) and (EI*) (E + I ⇔ EI ⇔ EI* ) was achieved, which was characterized by the constant urease activity, since the slow-binding effect would not be revealed unless the enzyme interacted with the inhibitor for sufficient time. Otherwise, it would lead to a misinterpretation as a noncompetitive type if determined by the initial reaction rates method. Hence, the progress curves analysis was employed to confirm the slow-binding model of JBU inactivation by ASB.

Fig. 3
figure 3

Lineweaver-Burk plot of the reciprocal of urease activity versus reciprocal of substrate concentration in the absence and presence of 2 mM, 4 mM, and 6 mM of ASB

Full size image
Fig. 4
figure 4

Dependence of residual activity versus preincubation time with ASB. Concentration of ASB (mM) is numerically given

Full size image

Progress curves analysis

The progress curves for urea hydrolysis under ASB-inhibited JBU catalyzation were shown in Fig. 5. The reaction progress curves for the unpreincubated system were concave downward (Fig. 5(a)), indicating that the velocity of urea hydrolysis decreased from an initial velocity (v 0 ) to a much slower steady-state velocity (v s ) according to the apparent first-order velocity constant k app . Such a behavior is characteristic of slow-binding inhibition elaborated by the theory of Morrison and Walsh. The obtained results also showed that the v 0 and v s were inhibitor concentration-dependent. In terms of the preincubation system (steady-state analysis, Fig. 5(b)), the linear curves proved that the reaction achieved the steady-state velocity (v s ), being different from each studied inhibitor concentration.

Fig. 5
figure 5

a Reaction progress curves of urease-catalyzed hydrolysis of urea in the presence of ASB; b Steady-state analysis: concentration of ammonia versus time. ASB concentration (mM) is numerically given

Full size image

The obtained relationship of the reaction velocities (v 0 ; v s ) versus the inhibitor concentration is characteristic of a two-step enzyme inhibitor interaction, mechanism B described as follows,

$$ \begin{array}{l}E+S\underset{k_2}{\overset{k_1}{\leftrightarrow }}\kern0.2em ES\overset{k^7}{\to }E+P\\ {}E+I\underset{k_4}{\overset{k_3}{\leftrightarrow }}\kern0.5em \underset{\mathrm{slow}}{\underbrace{EI\underset{k_6}{\overset{k_5}{\leftrightarrow }}EI\;}}*\end{array} $$
(2)

where E is enzyme, S is substrate, P is product, I is inhibitor, and EI and EI* are enzyme-inhibitor complexes, respectively. k 1 -k 7 are velocity constants. Linear dependencies of 1/v 0 and 1/v s on the inhibitor concentration are used to evaluate the inhibition constants, K i and K i *, as follows:

$$ \begin{array}{l}\frac{1}{vo}=\frac{KM}{v \max SoKi}I+\frac{1}{v \max}\left(1+\frac{KM}{So}\right)\\ {}\frac{1}{vs}=\frac{KM}{v \max SoKi*}I+\frac{1}{v \max}\left(1+\frac{KM}{So}\right)\end{array} $$
(3)

where K M is the Michaelis constant and v max is the maximum velocity given by the Michaelis-Menten equation for the uninhibited reaction; S 0 denotes the initial concentration of urea; K i and K i * are the inhibition constants defined as: K i = [E] [I] / [EI] and K i * = [E] [I] / ( [EI] + [EI*] ) respectively.

By calculating from reciprocal dependence of v 0 and v s on the inhibitor concentration according to formula [3], it was found that the initial ASB-JBU complex formed rapidly with an inhibition constant of K i  = (2.86 ± 0.09) × 10−3 mM, followed by a slow isomerization into the final ASB-urease complex with the overall inhibition constant of K i * = (1.33 ± 0.11) × 10−4 mM. The rate constant of the ASB-JBU isomerization indicated that forward process was rapid in contrast with slow reverse reactions. The overall inhibition constant obtained by the steady-state analysis was (1.18 ± 0.13) × 10−3 mM. Furthermore, the shape of the curves in that case corresponded to the competitive slow-binding type of inhibition, as represented by formula [1]. In details, the reaction was inhibited slightly in the initial period, characterized by high reaction rates v 0 . Then, in the later period, the inhibition became stronger, characterized by lower reaction rates v s . This indicated a competitive inhibition in both initial and steady-state stages of the inhibition reaction.

Taken together, the progress curves analysis and preincubation studies proved that the ASB inhibition on urease was indeed in a slow-binding and competitive manner.

Urease protection against ASB inactivation

Up to now, it has been found that there were two well-defined urease protectors. One is the inorganic compounds (NaF and boric acid) reacting with active-site nickel ions, and the other is thiol-containing compounds such as DTT and L-cys, which interact with sulfhydryl groups of urease [35, 36]. When equilibrated with the enzyme, the protectors by occupying the active site restrict the accessibility of inhibitions to the active-site functional groups. Hence, in the present investigation, both protectors were employed to investigate the possible inhibition target of ASB. According to Fig. 6(a), the urease protection effect against inactivation by ASB was enhanced as the concentration of thiol reagents increased. After the inactivation by 4 mM ASB, L-cys and DTT could restore the urease activity in a concentration-dependent manner. This indicated that the thiol groups were involved in the inactivation of the enzyme and that there was a better affinity of ASB towards L-cys and DTT than the thiol group in urease. Meanwhile, the protective potency of L-cys was found stronger than that of DTT. This might be due to the pH of the reaction system (pH = 6.9-7.0), in which DTT failed to exert the desired protective effect [37]. By contrast, protections with sodium fluoride (a competitive slow-binding urease inhibitor) [35] and boric acid (a classical competitive urease inhibitor) [35, 36] were relatively insignificant. As Fig. 6(b) demonstrated, when urease was inactivated by ASB in the presence of sodium fluoride and boric acid, the enzymatic activity decreased to 11.42 % and 15.61 %, respectively, even lower than that in the presence of ASB alone, suggesting a probable synergic relationship between ASB and sodium fluoride or boric acid. Obviously, better prevention by thiols than by inorganic compounds against ASB inactivation indicated that the active-site sulfhydryl group might be a residue responsible for urease inhibition.

Fig. 6
figure 6

a L-cys and DTT protection of urease against ASB. Concentration of L-cys and DTT (mM) is numerically given; b Protection of urease against ASB inactivation by boric acid and sodium fluoride

Full size image

ASB-thiol-urease interaction test

The role of thiols in ASB inactivation was studied by comparing urease activities in thiol-free system at three time points of incubation. It was found that monothiol (L-cys) and dithiol (DTT) could alleviate the inactivation by ASB, and urease regained activity in spite of ASB presenting in the incubation mixture. When the thiol-containing compounds provided thiol groups, concentration was equal or higher than that of ASB. However, as Fig. 7(a and b) shown, incubation time had no significant effect on the ASB-thiol-urease interaction. And the protection potency remained consistent regardless of the addition order of urease, inhibitors, and protectors.

Fig. 7
figure 7

a Thiol influence on urease inactivation by ASB relative to the control activity. The percent of the enzyme activity in the presence of ASB without the thiol is given as comparison. Concentration of the thiol: L-cys, DTT, and ASB were 4 mM. Enzyme activity was determined after 10, 30, 60 min of incubation; b Influence of thiol order of components preincubation on urease inactivation by ASB. The initial 20 min preincubation mixture contained components given in brackets. The preincubation was continued the further 20 min after addition of the last component (component given outside for brackets). The final preincubation mixtures contained 0.25 mg/mL urease, 20 mM phosphate buffer, pH 7.0, 2 mM EDTA, 4 mM ASB, and DTT or L-cys. Enzyme activity was determined after 40 min of preincubation time. The percent of the enzyme activity in the presence of ASB without the thiol is given for comparison

Full size image

The presence of the thiol-protector in the incubation system allowed ASB to react with thiols from the JBU and those in the “free” thiol-protector. The thiols presenting in the protein were much less reactive than those presenting externally in the form of L-cys or DTT. The decreases of urease activity in the thiol-free system and system with the thiols were compared, suggesting that the general losses of urease activity in both systems remained, but it was slowed down in the presence of thiols, especially in the presence of L-cys. These data suggested that ASB-thiol interaction was strategic for the inactivation rate decrease.

Reactivation of ASB-inactivated urease

To investigate whether the inactivation of JBU by ASB was reversible, the reactivation of ASB-inactivated JBU was carried out in two ways. In the first way, by addition of L-cys or DTT after the 20 min incubation of JBU with ASB, urease activity recovered in a time-dependent manner: after 1.5 h, JBU had restored 90.77 % and 70.98 % of its initial activity, respectively (Fig. 8). After reactivated by L-cys or DTT, retreatment of ASB could not inhibit the urease activity again. This evidence indicated that the urease-ASB complex was less resistant for chemical approach.

Fig. 8
figure 8

Reactivation of ASB-inactivated urease by L-cys or DTT. Activity of urease inactivated by ASB (blue line) and after adding L-cys (yellow) or DTT (purple). Urease was inactivated by 4 mM ASB, and 4 mM L-cys or DTT was added into the reaction system 20 min later (as indicated by the vertical arrow)

Full size image

By contrast, by multidilution, urease remained in constant activity as the concentration of ammonia increased, which indicated that an insignificant amount of the active enzyme separated from urease-ASB complex after dilution due to no further release of active urease (data not shown). Taken together, there would be a supposed reversibility between urease and ASB, in which the chemical approach but not multidilution could recover the enzyme activity that had been inactivated by ASB.

Molecular docking

In order to elucidate the inhibition mechanism revealed by the kinetics study, molecular docking of ASB into the crystal structure of JBU (3LA4 in the Protein Data bank) was performed by the AutoDock program, and the best possible binding modes were shown in Fig. 9.

Fig. 9
figure 9

a Molecular docking simulations obtained at the lowest energy conformation, highlighting potential hydrogen contacts of ASB. For clarity, only interacting residues are labeled. Hydrogen bonding interactions are shown by dashes; b Surface representation of the active-site flap of JBU with ASB shown at the entrance of the binding pocket. (colored by atom: carbon is yellow; oxygen is red; hydrogen is white; sulfur is brown; nitrogen was blue)

Full size image

In the best possible binding mode, ASB tightly anchored the helix-turn-helix motif over the active-site cavity through O − H∙ ∙ ∙S, N − H∙ ∙ ∙O, and O − H∙ ∙ ∙O hydrogen bonding interactions. This mode made ASB engage a cleft beside the active-site cavity, using 3 typical hydrogen bonds to anchor the flap tightly with the backbone of the enzyme, thereby preventing the flap from backing to the close position. The 12- SO3H of ASB, as the hydrogen bond donor ,was found between the OH and the backbone S atom of CME 592 (H∙ ∙ ∙S distance = 2.7 Å), which was located on the mobile flap closing the active site of the enzyme. In addition, the 12- SO3H of ASB was bound via two hydrogen bonds to NH2 of ARG 439 with O∙∙∙H distance of 2.7 Å and 2.8 Å, respectively. The Cys-592 (marked as CME592) is a key residue located at the mobile flap covering the active site, one per each of the six sites in the hexameric molecule [38]. Besides being directly involved in the architecture of the active site, the residue has a vital role in positioning other key residues in the active site appropriately for the catalysis [28, 39]. The flexible flap goes through an open-closed-open procedure, effectively activating the inert urea leading to activated enzyme during the normal urea catalyzed by urease [40]. And modification of Cys-592 resulted in restriction of the mobility of the flap, subsequently perturbed the reaction, and reduced enzymatic activity. In addition, ARG-439, the other residue of the flap at the entrance of the binding pocket, participate in the substrate binding, stabilize the catalytic transition state, and accelerate the reaction mainly through hydrogen bonding. It was reported that some urease inhibitors depressed JBU activities by interacting with the sulfhydryl group of residues, especially the Cys-592 [41].

As the results described, ASB possibly made hydrogen bonding interactions with the side chains of the above-mentioned residues, especially the active-site flap Cys-592, hence preserving the flap in an open conformation and resulting in an inactivation. The observation was soundly supportive of the earlier conclusion drawn from the urease protection experiments performed with the active-site binding inhibitors, which supported the observation that inhibition by ASB involved the participation of sulfhydryl group of the active-site cysteine. Taking into account the peculiarities of the active-site flap cysteine in the urease catalysis and sulfhydryl group in urease activity, it could be inferred that ASB made contacts with the side chains of cysteine residues, especially sulfhydryl group, which was reflected in their enhanced affinity to the Cys-592. As a result, the mobility of flap was restricted, and the enzymatic activity significantly declined finally.

Conclusions

Based on the research on the mechanism and kinetics of urease inhibition by ASB in the present study, it could be concluded that ASB was a competitive inhibitor targeting thiol groups in the active site of urease in a slow-binding manner, both concentration dependent and reversible. Hence, ASB deserves to be further exploited as a promising urease inhibitor for treatments of urease-related diseases.

Abbreviations

ASB:

Andrographolide sodium bisulphite

JBU:

Jack bean urease

HPU:

Helicobacter pylori urease

DTT:

D,L-dithiothreitol

L-cys:

L-cysteine

NaF:

Sodium fluoride

EDTA:

Ethylene diamine tetraacetic acid

PBS:

Phosphate buffer

LGA:

The Lamarckian genetic algorithm

RMSD:

Root-mean-square deviation

References

  1. Krajewska B. Ureases I. Functional, catalytic and kinetic properties: a review. J Mol Catal B Enzym. 2009;59(1–3):9–21.

    Article  CAS  Google Scholar 

  2. Dixon NE, Gazzola C, Watters JJ, Blakely RL, Zerner B. Inhibition of Jack Bean urease (EC 3.5.1.5) by acetohydroxamic acid and by phosphoramidate. An equivalent weight for urease. J Am Chem Soc. 1975;97(14):4130–1.

    Article  CAS  PubMed  Google Scholar 

  3. Carter EL, Tronrud DE, Taber SR, Karplus PA, Hausinger RP. Iron-containing urease in a pathogenic bacterium. Proc Natl Acad Sci U S A. 2011;108(32):13095–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Sumner JB. The isolation and crystallization of the enzyme urease preliminary paper. J Biol Chem. 1926;69(2):435–41.

    CAS  Google Scholar 

  5. Marshall BJ, Barrett LJ, Prakash C, McCallum RW, Guerrant RL. Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acid. Gastroenterology. 1990;99(3):697–702.

    Article  CAS  PubMed  Google Scholar 

  6. Dixon NE, Hinds JA, Fihelly AK, Gazzola C, Winzor DJ, Blakeley RL, et al. Jack bean urease (EC 3.5.1.5). IV. The molecular size and the mechanism of inhibition by hydroxamic acids. Spectrophotometric titration of enzymes with reversible inhibitors. Can J Biochem. 1980;58(12):1323–34.

    Article  CAS  PubMed  Google Scholar 

  7. Breitenbach JM, Hausinger RP. Proteus mirabilis urease. Partial purification and inhibition by boric acid and boronic acids. Biochem J. 1988;250(3):917–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Krajewska B. Mono- (Ag, Hg) and di- (Cu, Hg) valent metal ions effects on the activity of jack bean urease. Probing the modes of metal binding to the enzyme. J Enzyme Inhib Med Chem. 2008;23(4):535–42.

    Article  CAS  PubMed  Google Scholar 

  9. Kot M, Zaborska W. Inhibition of jack bean urease by tetrachloro-o-benzoquinone and tetrachloro-p-benzoquinone. J Enzyme Inhib Med Chem. 2006;21(5):537–42.

    Article  CAS  PubMed  Google Scholar 

  10. Kuhler TC, Fryklund J, Bergman NA, Weilitz J, Lee A, Larsson H. Structure-activity relationship of omeprazole and analogues as Helicobacter pylori urease inhibitors. J Med Chem. 1995;38(25):4906–16.

    Article  CAS  PubMed  Google Scholar 

  11. Shao ZJ, Zheng XW, Feng T, Huang J, Chen J, Wu YY, et al. Andrographolide exerted its antimicrobial effects by upregulation of human beta-defensin-2 induced through p38 MAPK and NF-kappaB pathway in human lung epithelial cells. Can J Physiol Pharmacol. 2012;90(5):647–53.

    Article  CAS  PubMed  Google Scholar 

  12. Chen HW, Lin AH, Chu HC, Li CC, Tsai CW, Chao CY, et al. Inhibition of TNF-alpha-induced inflammation by andrographolide via down-regulation of the PI3K/Akt signaling pathway. J Nat Prod. 2011;74(11):2408–13.

    Article  CAS  PubMed  Google Scholar 

  13. Chiou WF, Lin JJ, Chen CF. Andrographolide suppresses the expression of inducible nitric oxide synthase in macrophage and restores the vasoconstriction in rat aorta treated with lipopolysaccharide. Br J Pharmacol. 1998;125(2):327–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Rajagopal S, Kumar RA, Deevi DS, Satyanarayana C, Rajagopalan R. Andrographolide, a potential cancer therapeutic agent isolated from Andrographis paniculata. J Exp Ther Oncol. 2003;3(3):147–58.

    Article  CAS  PubMed  Google Scholar 

  15. Shen YC, Chen CF, Chiou WF. Andrographolide prevents oxygen radical production by human neutrophils: possible mechanism(s) involved in its anti-inflammatory effect. Br J Pharmacol. 2002;135(2):399–406.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Handa SS, Sharma A. Hepatoprotective activity of andrographolide against galactosamine & paracetamol intoxication in rats. Indian J Med Res. 1990;92:284–92.

    CAS  PubMed  Google Scholar 

  17. Trivedi NP, Rawal UM, Patel BP. Potency of andrographolide as an antitumor compound in BHC-induced liver damage. Integr Cancer Ther. 2009;8(2):177–89.

    Article  CAS  PubMed  Google Scholar 

  18. Saranya P, Geetha A, Selvamathy SMKN. A biochemical study on the gastroprotective effect of andrographolide in rats induced with gastric ulcer. Indian J Pharm Sci. 2011;73(5):550–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Chen ZL, Xu HP. 45 cases of application of Andrographis paniculata for treatment on Helicobacter pylori-associated children gastritis. Chin J Integr Tradit West Med. 2004;21:485.

    Google Scholar 

  20. Wu GX, Zhang JB, Wang SP. Application of Andrographis paniculata for treatment of Helicobacter pylori-associated positive digestive ulcer. Chin J Clin Res. 2003;11(79):13122-3.

  21. Zhang XF, Tan BK. Anti-diabetic property of ethanolic extract of Andrographis paniculata in streptozotocin-diabetic rats. Acta Pharmacol Sin. 2000;21(12):1157–64.

    CAS  PubMed  Google Scholar 

  22. Zhang XF, Tan BK. Antihyperglycaemic and anti-oxidant properties of Andrographis paniculata in normal and diabetic rats. Clin Exp Pharmacol Physiol. 2000;27(5-6):358–63.

    Article  CAS  PubMed  Google Scholar 

  23. Xu HW, Dai GF, Liu GZ, Wang JF, Liu HM. Synthesis of andrographolide derivatives: a new family of alpha-glucosidase inhibitors. Bioorg Med Chem. 2007;15(12):4247–55.

    Article  CAS  PubMed  Google Scholar 

  24. Follmer C, Pereira FV, Da Silveira NP, Carlini CR. Jack bean urease (EC 3.5.1.5) aggregation monitored by dynamic and static light scattering. Biophys Chem. 2004;111(1):79–87.

    Article  CAS  PubMed  Google Scholar 

  25. Sheridan L, Wilmot CM, Cromie KD, van der Logt P, Phillips SE. Crystallization and preliminary X-ray structure determination of jack bean urease with a bound antibody fragment. Acta Crystallogr Sect D: Biol Crystallogr. 2002;58(Pt 2):374–6.

    Article  Google Scholar 

  26. Follmer C. Insights into the role and structure of plant ureases. Phytochemistry. 2008;69(1):18–28.

    Article  CAS  PubMed  Google Scholar 

  27. Shabana S, Kawai A, Kai K, Akiyama K, Hayashi H. Inhibitory activity against urease of quercetin glycosides isolated from Allium cepa and Psidium guajava. Biosci Biotechnol Biochem. 2010;74(4):878–80.

    Article  CAS  PubMed  Google Scholar 

  28. Norris R, Brocklehurst K. A convenient method of preparation of high-activity urease from Canavalia ensiformis by covalent chromatography and an investigation of its thiol groups with 2,2′-dipyridyl disulphide as a thiol titrant and reactivity probe. Biochem J. 1976;159(2):245–57.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Ciurli S, Benini S, Rypniewski WR, Wilson KS, Miletti S, Mangani S. Structural properties of the nickel ions in urease: novel insights into the catalytic and inhibition mechanisms. Coord Chem Rev. 1999;190–192:331–55.

    Article  Google Scholar 

  30. Shibata H, Iimuro M, Uchiya N, Kawamori T, Nagaoka M, Ueyama S, et al. Preventive effects of Cladosiphon fucoidan against Helicobacter pylori infection in Mongolian gerbils. Helicobacter. 2003;8(1):59–65.

    Article  CAS  PubMed  Google Scholar 

  31. Ohta T, Shibata H, Kawamori T, Iimuro M, Sugimura T, Wakabayashi K. Marked reduction of Helicobacter pylori-induced gastritis by urease inhibitors, acetohydroxamic acid and flurofamide, in Mongolian gerbils. Biochem Biophys Res Commun. 2001;285(3):728–33.

    Article  CAS  PubMed  Google Scholar 

  32. Weatherburn MW. Phenol-hypochlorite reaction for determination of ammonia. Anal Chem. 1967;39(8):971–4.

    Article  CAS  Google Scholar 

  33. The PyMOL Molecular Graphics System. [http://www.pymol.org]

  34. Krajewska B, Zaborska W, Leszko M. Inhibition of chitosan-immobilized urease by slow-binding inhibitors: Ni2+, F− and acetohydroxamic acid. J Mol Catal B Enzym. 2001;14(4–6):101–9.

    Article  CAS  Google Scholar 

  35. Dixon NE, Blakeley RL, Zerner B. Jack bean urease (EC 3.5.1.5). III. The involvement of active-site nickel ion in inhibition by beta-mercaptoethanol, phosphoramidate, and fluoride. Can J Biochem. 1980;58(6):481–8.

    Article  CAS  PubMed  Google Scholar 

  36. Morrison JF, Walsh CT. The behavior and significance of slow-binding enzyme inhibitors. Adv Enzymol Relat Areas Mol Biol. 1988;61:201–301.

    CAS  PubMed  Google Scholar 

  37. Cleland WW. Dithiothreitol, a new protective reagent for SH groups. Biochemistry. 1964;3:480–2.

    Article  CAS  PubMed  Google Scholar 

  38. Takishima K, Suga T, Mamiya G. The structure of jack bean urease. The complete amino acid sequence, limited proteolysis and reactive cysteine residues. Eur J Biochem / FEBS. 1988;175(1):151–65.

    Article  CAS  Google Scholar 

  39. Todd MJ, Hausinger RP. Identification of the essential cysteine residue in Klebsiella aerogenes urease. J Biol Chem. 1991;266(36):24327–31.

    CAS  PubMed  Google Scholar 

  40. Benini S, Ciurli S, Nolting HF, Mangani S. X-ray absorption spectroscopy study of native and phenylphosphorodiamidate-inhibited Bacillus pasteurii urease. Eur J Biochem / FEBS. 1996;239(1):61–6.

    Article  CAS  Google Scholar 

  41. Krajewska B, Zaborska W. Jack bean urease: the effect of active-site binding inhibitors on the reactivity of enzyme thiol groups. Bioorg Chem. 2007;35(5):355–65.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by grants from National Science Foundation of China (Nos. 81374043 & 81173534), Ph.D. Programs Foundation of Ministry of Education of China (No. 20134425110009), Science and Technology Innovation Project of Guangdong Provincial Department of Education (No. 2013KJCX0045), Science and Technology Planning Project of Guangdong Province (No. 2014A020221042), the Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2011) and the Special Funds from Central Finance of China in Support of the Development of Local Colleges and University--Educational finance Grant No.276 (2014).

Author information

Author notes

    Authors and Affiliations

    1. Guangdong Provincial Key Laboratory of of New Chinese Medicinals Development and Research, Guangzhou University of Chinese Medicine, Guangzhou, 510006, P. R. China

      Zhi-Zhun Mo, Xiu-Fen Wang, Xie Zhang, Ji-Yan Su, Hai-Ming Chen, Yu-Hong Liu, Zhen-Biao Zhang & Zi-Ren Su

    2. Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, The Second Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, 510120, P. R. China

      Jian-Hui Xie

    3. Dongguan Mathematical Engineerings Academy of Chinese Medicine, Guangzhou University of Chinese Medicine, Dongguan, 523000, P. R. China

      Zi-Ren Su

    Authors
    1. Zhi-Zhun Mo
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Xiu-Fen Wang
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Xie Zhang
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Ji-Yan Su
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Hai-Ming Chen
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Yu-Hong Liu
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Zhen-Biao Zhang
      View author publications

      You can also search for this author in PubMed Google Scholar

    8. Jian-Hui Xie
      View author publications

      You can also search for this author in PubMed Google Scholar

    9. Zi-Ren Su
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding authors

    Correspondence to Jian-Hui Xie or Zi-Ren Su.

    Additional information

    Competing interests

    The authors declare that they have no competing interests.

    Authors’ contributions

    All authors participated in the acquisition of data and revision of the manuscript. All authors conceived of the study, determined the design, interpreted the data and drafted the manuscript. All authors read and approved the final manuscript.

    Zhi-Zhun Mo, Xiu-Fen Wang and Xie Zhang contributed equally to this work.

    Rights and permissions

    Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

    The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

    To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.

    The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Mo, ZZ., Wang, XF., Zhang, X. et al. Andrographolide sodium bisulphite-induced inactivation of urease: inhibitory potency, kinetics and mechanism. BMC Complement Altern Med 15, 238 (2015). https://doi.org/10.1186/s12906-015-0775-4

    Download citation

    • Received:

    • Accepted:

    • Published:

    • DOI: https://doi.org/10.1186/s12906-015-0775-4

    Keywords

    BMC Complementary Medicine and Therapies

    ISSN: 2662-7671

    Contact us